We are live on
!
Find out more
PCC
Park Circle Company Portfolio holdings
AUM
$108M
1-Year Est. Return
15.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.17%
1 Year Est. Return
+15.4%
3 Year Est. Return
+58.12%
5 Year Est. Return
+71.13%
10 Year Est. Return
+224%
AUM
$114M
AUM Growth
+$1.57M
(+1.4%)
Cap. Flow
-$1.84M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
58.26%
Holding
115
New
7
Increased
6
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$1.14M |
| 2 |
Global X NASDAQ-100 Covered Call ETF
QYLD
|
+$529K |
| 3 |
Scotiabank
BNS
|
+$527K |
| 4 |
Lincoln National
LNC
|
+$509K |
| 5 |
Blue Owl Capital
OBDC
|
+$176K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.74M |
| 2 |
M&T Bank
MTB
|
+$1.12M |
| 3 |
Starbucks
SBUX
|
+$1.06M |
| 4 |
Kohl's
KSS
|
+$441K |
| 5 |
Sarepta Therapeutics
SRPT
|
+$225K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.13% |
| 2 | Healthcare | 15.97% |
| 3 | Consumer Staples | 9.45% |
| 4 | Consumer Discretionary | 6.93% |
| 5 | Communication Services | 6.83% |
Similar funds
IPS
HPM
GCCM
SFAM
CCMW
VWM
BAM
PFG
Park Circle Company's Q1 2025 Portfolio in Review
As of Q1 2025, Park Circle Company held 115 positions worth $114M, up 1.4% from $112M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Park Circle Company's Q1 2025 filing shows 7 new, 6 increased, 7 reduced and 4 closed positions. Its largest new stake was Global X NASDAQ-100 Covered Call ETF: 29,500 shares worth $491K. The largest sale was IBM, an estimated $1.74M.
By sector, the portfolio is most concentrated in Financials at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Staples.
- Park Circle Company's largest Q1 2025 buy was Global X NASDAQ-100 Covered Call ETF: 29,500 shares worth $491K.
- Park Circle Company added most to T. Rowe Price in Q1 2025, an estimated $1.14M increase.
- Park Circle Company's biggest Q1 2025 reduction was IBM, cutting an estimated $1.74M.
- Park Circle Company fully exited Sarepta Therapeutics in Q1 2025, selling an estimated $225K.
- Park Circle Company's ten largest holdings make up 58% of its $114M portfolio in Q1 2025.
- Park Circle Company opened 7 new positions and closed 4 in Q1 2025.
- Park Circle Company's portfolio value rose 1.4% quarter-over-quarter to $114M.
Based on Park Circle Company's 13F filing for Q1 2025, filed 9 May 2025.